DUBLIN – (BUSINESS WIRE) – July 2, 2021–

The report “Global HPV Testing and Pap Testing Market by Type, Application, Product, End Use, Regional Outlook, Industry Analysis Report and Forecast, 2021-2027” has been added to the offering from ResearchAndMarkets.com.

The global HPV and Pap Test market size is expected to reach $ 7.1 billion by 2027, with market growth of 33.5% CAGR during the forecast period.

Both Pap tests and HPV tests are included in screening for cervical cancer, which is a crucial part of a woman’s routine check-up as it can uncover cancer or abnormalities that can lead to cervical cancer. cancer of the cervix. It is suggested that a woman should have a Pap test every 3 years from the age of 21.

In addition, it is further recommended that women between the ages of 30 and 65 have a Pap and HPV every 5 years or a Pap test every 3 years. Women with certain risk factors may require more frequent screening or may continue to screen themselves even after the age of 65.

Some of the determinants driving the demand and growth for HPV and Pap tests are constant technological developments, an increasing number of cervical cancer screening programs, and the increase in cervical cancer cases. ‘uterus. On the other hand, the global COVID-19 crisis and the imposition of various lockdown standards and restrictions to keep people in their homes have dramatically reduced routine cancer screenings.

Impact of COVID-19

Interruptions in cancer screening services have been observed in the majority of settings due to the global coronavirus crisis. Guidelines for cancer screening activities are usually created after a systematic and careful review of the evidence available in an optimal way to provide high quality care and reduce variability in clinical practice.

However, the onset of the COVID-19 pandemic required an instant response at a time when the duration of the pandemic could not be predicted and the nature of the virus was still largely unidentified. In the majority of contexts, the consequence of this situation was a postponement of services for a limited time. These disruptions are expected to lead to very advanced cancer diagnoses and deaths over the next few years.

Testing services have now restarted to some extent in most countries; However, the aftermath of the deadly COVID-19 outbreak continues to disrupt healthcare delivery. Despite the approval of various safe and highly effective COVID-19 vaccines, supply constraints have delayed their deployment. Therefore, the current disruptions in healthcare, in general, are expected to remain the same for some time. Therefore, the outbreak of the COVID-19 pandemic has negatively impacted the HPV testing and Pap testing market.

The market research report covers the analysis of the major stakeholders of the market.

Key companies described in the report include

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltée.
  • Thermo Fisher Scientific, Inc.
  • Becton, Dickinson and company
  • Hologic, Inc.
  • Quest Diagnostics, Incorporated
  • Seegene, Inc.
  • Arbor Vita Corporation
  • Femasys, Inc.
  • Qiagen SA

Main topics covered:

Chapter 1. Market Scope and Methodology

1.1 Market definition

1.2 Objectives

1.3 Scope of the market

1.4 Segmentation

Chapter 2. Market Overview

2.1 Presentation

2.1.1 Overview

2.1.2 Market composition and scenario:

2.2 Key factors influencing the market

2.2.1 Market drivers

2.2.2 Market restrictions

2.2.3 Market opportunity

Chapter 3. Global HPV and Pap Test Market by Type

3.1 Global Pap Test Market by Region

3.2 Global HPV Testing Market by Region

Chapter 4. Global HPV Testing and Pap Testing Market by Application

4.1 Global Cervical Cancer Screening Market by Region

4.2 Global Breast Cancer Screening Market by Region

Chapter 5. Global HPV and Pap Test Market by Product

5.1 Global Consumables Market by Region

5.2 Global Instrumentation Market by Region

5.3 Global Services Market by Region

Chapter 6. Global HPV Testing and Pap Testing Market by Technology

6.1 Global PCR Market by Region

6.2 Global Immunodiagnostics Market by Region

6.3 Global Other Technologies Market by Region

Chapter 7. Global HPV Testing and Pap Testing Market by End Use

7.1 Global Hospital and Clinic Market by Region

7.2 Global Laboratory Market by Region

7.3 Global Other End-Use Market by Region

Chapter 8. Global HPV Testing and Pap Testing Market by Region

Chapter 9. Company Profiles

For more information on this report, visit https://www.researchandmarkets.com/r/jjkq7r

See the source version on businesswire.com: https://www.businesswire.com/news/home/20210702005152/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Director

press@researchandmarkets.com

For EST office hours, call 1-917-300-0470

For USA / CAN call toll free 1-800-526-8630

For GMT office hours, call + 353-1-416-8900

KEYWORD:

INDUSTRY KEYWORD: HEALTH ONCOLOGY

SOURCE: Research and markets

Copyright Business Wire 2021.

PUB: 02/07/2021 07:23 / DISC: 02/07/2021 07:23

http://www.businesswire.com/news/home/20210702005152/en

Copyright Business Wire 2021.